Condensed Consolidated Statements of Stockholders' Deficiency - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)			153,959,427
Beginning Balance	$ (840,652)	$ (656,499)	$ (841,553)	$ (659,687)
Net income	39,153	93,305	71,695	125,262
Total other comprehensive income	295	287	552	476
Distributions and dividends on common stock	(31,759)	(31,610)	(63,526)	(63,228)
Restricted stock grants		0	0	0
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting	(519)	(608)	(1,557)	(608)
Stock-based compensation	2,570	3,080	4,717	5,740
Reallocation of distribution of Douglas Elliman	$ 0		0
Other			$ (1,240)
Ending Balance (in shares)	154,896,129		154,896,129
Ending Balance	$ (830,912)	$ (592,045)	$ (830,912)	$ (592,045)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	154,938,177	154,194,629	153,959,427	153,324,629
Beginning Balance	$ 15,494	$ 15,419	$ 15,396	$ 15,332
Restricted stock grant (in shares)		3,500	1,070,000	873,500
Restricted stock grants		$ 1	$ 107	$ 88
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting (in shares)	(42,048)	(42,029)	(133,298)	(42,029)
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting	$ (4)	$ (4)	$ (13)	$ (4)
Ending Balance (in shares)	154,896,129	154,156,100	154,896,129	154,156,100
Ending Balance	$ 15,490	$ 15,416	$ 15,490	$ 15,416
Additional Paid-In
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	12,183	2,573	11,172	0
Restricted stock grants		(1)	(107)	(88)
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting	(515)	(604)	(1,544)	(604)
Stock-based compensation	2,570	3,080	4,717	5,740
Reallocation of distribution of Douglas Elliman	(11,172)		(11,172)
Ending Balance	3,066	5,048	3,066	5,048
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(852,863)	(653,606)	(852,398)	(653,945)
Net income	39,153	93,305	71,695	125,262
Distributions and dividends on common stock	(31,759)	(31,610)	(63,526)	(63,228)
Reallocation of distribution of Douglas Elliman	11,172		11,172
Other			(1,240)
Ending Balance	(834,297)	(591,911)	(834,297)	(591,911)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(15,466)	(20,885)	(15,723)	(21,074)
Total other comprehensive income	295	287	552	476
Ending Balance	(15,171)	(20,598)	(15,171)	(20,598)
Non-controlling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	0	0
Ending Balance	$ 0	$ 0	$ 0	$ 0